Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
126,882,307
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
44,814,450
-
Shares change
-
+304,425
-
Total reported value, excl. options
-
$173,427,573
-
Value change
-
+$1,498,150
-
Put/Call ratio
-
81%
-
Number of buys
-
31
-
Number of sells
-
27
-
Price
-
$3.87
Institutional Holders of Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share (NAUT) as of Q2 2023
As of 30 Jun 2023 Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share (NAUT) had 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 44,814,450 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, Cercano Management LLC, Madrona Venture Group, LLC, BlackRock Inc., VANGUARD GROUP INC, Comprehensive Financial Management LLC, Bain Capital Life Sciences Investors, LLC, AMAZON COM INC, ArchPoint Investors, and AH Equity Partners LSV II, L.L.C..
This table shows 74 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.